Cath-L-dBET1 is a PROTAC degrader targeting BRD4. It has an IC50 value of 2.8 µM in MDA-MB-231 cells. Activated by cathepsin L (Cath-L), Cath-L-dBET1 recruits E3 ubiquitin ligase to degrade BRD4 via the ubiquitin-proteasome system. Hyp-dBET1 is applicable for antitumor research.
Target:
PROTACs|||Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
